… In line with the purpose of this study on HBP and COVID-19 … the potential pathological roles
of HBP in severe COVID-19, its value as a therapeutic target is highlighted [62], eg by heparin…

Background Thrombosis and inflammation may contribute to the risk of death and
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that …

… ’ dosages and mortality, we used a Cox’s regression analysis, adjusted for potential
confounders. Confounders (ie age, sex, and presence of obesity, diabetes, cancer, COPD, dementia…

… detected in severe patients and heparin-induced thrombocytopenia (… COVID-19 patients
define a potential therapeutic option of using blocking antibodies in the treatment of COVID-19…

… This review focused on the new and old applications of heparin and discussed the potential
… thromboembolism rates in COVID-19 increase the possibility that heparin may benefit the …

… evidence the potential role of lactoferrin (LF) and heparin in coronavirus disease 2019 (COVID-19)…
Heparin and LF could reduce viral entry by preventing the attachment of severe acute …

… the lymphocytes (LYM%)of patients and has the potential for treatment of COVID-19. … of
patients with COVID-19 to investigate the anti-inflammatory effects of heparin and delay disease …

… Searching for repurposable drugs with potential targets among the … COVID-19, heparin
emerged as an interesting compound to pursue. The use of heparin for treating severe COVID-19-…

… No other potential conflict of interest relevant to this letter … for Covid-19, therapeutic-dose
anticoagulation with heparin was … dose anticoagulation with heparin increased organ support–…

… the 2019 Novel Coronavirus (COVID-19) outbreak and … drug or vaccine for COVID-19. The
pathogenic infectivity of the … , unfractioned heparin and LMWH can be potential inhibitors of …